Stoxx Europe 50
4.440,12
PKT
+1,78
PKT
+0,04
%
Werbung
Analysen zu Stoxx Europe 50-Werten
Datum | Rating | Analyst | |
---|---|---|---|
03.02.25 | Airbus Overweight | JP Morgan Chase & Co. | |
03.02.25 | Mercedes-Benz Group (ex Daimler) Outperform | RBC Capital Markets | |
03.02.25 | HSBC Sector Perform | RBC Capital Markets | |
03.02.25 | Enel Buy | Goldman Sachs Group Inc. | |
03.02.25 | Novartis Hold | Deutsche Bank AG | |
03.02.25 | Novartis Kaufen | DZ BANK | |
03.02.25 | LOréal Hold | Jefferies & Company Inc. | |
03.02.25 | Unilever Sell | UBS AG | |
03.02.25 | LOréal Neutral | UBS AG | |
03.02.25 | Nestlé Neutral | UBS AG | |
03.02.25 | Novartis Buy | UBS AG | |
03.02.25 | Sanofi Buy | UBS AG | |
03.02.25 | Airbus Neutral | UBS AG | |
03.02.25 | HSBC Buy | Goldman Sachs Group Inc. | |
03.02.25 | HSBC Hold | Deutsche Bank AG | |
03.02.25 | AB InBev SA-NV (Anheuser-Busch InBev) Buy | Jefferies & Company Inc. | |
03.02.25 | Mercedes-Benz Group (ex Daimler) Hold | Jefferies & Company Inc. | |
31.01.25 | Sanofi Kaufen | DZ BANK | |
31.01.25 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
31.01.25 | LVMH Moet Hennessy Louis Vuitton Outperform | RBC Capital Markets | |
31.01.25 | Roche Sell | Deutsche Bank AG | |
31.01.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
31.01.25 | Novartis Buy | UBS AG | |
31.01.25 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
31.01.25 | Roche Neutral | UBS AG | |
31.01.25 | LOréal Neutral | UBS AG | |
31.01.25 | Sanofi Buy | UBS AG | |
31.01.25 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
31.01.25 | Intesa Sanpaolo Overweight | JP Morgan Chase & Co. | |
31.01.25 | UBS Overweight | JP Morgan Chase & Co. | |
31.01.25 | Novartis Outperform | Bernstein Research | |
31.01.25 | Prosus Overweight | JP Morgan Chase & Co. | |
31.01.25 | Sanofi Hold | Deutsche Bank AG | |
31.01.25 | Novartis Hold | Jefferies & Company Inc. | |
31.01.25 | SAP Buy | Goldman Sachs Group Inc. | |
31.01.25 | ASML NV Outperform | Bernstein Research | |
31.01.25 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
30.01.25 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
30.01.25 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
30.01.25 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets |